The Black Swan Research Initiative® and a Paradigm Shift in the Treatment of Multiple Myeloma

Brian G.M. Durie, MD, chairman, International Myeloma Foundation (IMF), hematologist/oncologist, Cedars-Sinai Medical Center, Los Angeles, California, discusses the Black Swan Research Initiative® of the IMF and a paradigm shift in the treatment of multiple myeloma.

Clinical Pearls

Brian G.M. Durie, MD, chairman, International Myeloma Foundation (IMF), hematologist/oncologist, Cedars-Sinai Medical Center, Los Angeles, California, discusses the Black Swan Research Initiative® of the IMF and a paradigm shift in the treatment of multiple myeloma.

  • Many investigators are interested in the Black Swan Research Initiative to study minimal residual disease (MRD) or to study treatments that could achieve MRD-Zeroâ„¢
  • Durie believes the time is right to not just compare treatments for multiple myeloma but to see if the disease is curable